Cargando…

Prevention of venous thromboembolism in patients with cancer with direct oral anticoagulants: A systematic review and meta-analysis

BACKGROUND: Patients with cancer are of a high level risk of venous thromboembolism (VTE). Low molecular weight heparin (LMWH) is recommended as the normal treatment for cancer-associated venous thrombosis. Recently, some studies suggest that patients with cancer-associated venous thrombosis can get...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hailong, Tao, Rui, Zhao, Hui, Jiang, Jianjun, Yang, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004711/ https://www.ncbi.nlm.nih.gov/pubmed/32000440 http://dx.doi.org/10.1097/MD.0000000000019000

Ejemplares similares

Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Farge, Dominique, et al.
Publicado: (2015)

Association between thyroid dysfunction and venous thromboembolism: A systematic review and meta-analysis
por: Wang, Yunmeng, et al.
Publicado: (2023)

Integrative analyses of genes about venous thromboembolism: An umbrella review of systematic reviews and meta-analyses
por: Lee, Sangyeob, et al.
Publicado: (2022)

Risk indicators for venous thrombosis in first-degree relatives of patients with recurrent venous thromboembolism in Chinese
por: Zhao, Lianxing, et al.
Publicado: (2016)

Identification of biomarkers of venous thromboembolism by bioinformatics analyses
por: Wang, Guiming, et al.
Publicado: (2018)

The safety and effectiveness of salvianolate in preventing perioperative venous thromboembolism in China: A PRISMA-compliant meta-analysis based on RCTs
por: Chai, Yu-na, et al.
Publicado: (2021)

Relationship between thrombomodulin gene polymorphism and susceptibility to venous thromboembolism: A protocol for systematic review and meta-analysis
por: Wei, Meihao, et al.
Publicado: (2021)

Direct oral anticoagulants and venous thromboembolism
por: Franchini, Massimo, et al.
Publicado: (2016)

Comparison of the effects of left atrial appendage closure and oral anticoagulants in preventing stroke in patients with non-valvular atrial fibrillation: A protocol for systematic review and meta-analysis
por: Yue, Deyong, et al.
Publicado: (2021)

Association of β-fibrinogen polymorphisms and venous thromboembolism risk: A PRISMA-compliant meta-analysis
por: Li, Da, et al.
Publicado: (2019)

Efficacy and Safety of Oral Anticoagulants Versus Aspirin for Patients With Atrial Fibrillation: A Meta-Analysis
por: Zhang, Jing-Tao, et al.
Publicado: (2015)

Venous thromboembolism has the same risk factors as atherosclerosis: A PRISMA-compliant systemic review and meta-analysis
por: Mi, Yuhong, et al.
Publicado: (2016)

The anticoagulants rivaroxaban and low molecular weight heparin prevent PICC-related upper extremity venous thrombosis in cancer patients
por: Lv, Shoutian, et al.
Publicado: (2019)

Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
por: Song, Andrew B, et al.
Publicado: (2019)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

It can be safe to discontinue oral anticoagulants after successful atrial fibrillation ablation: A systematic review and meta-analysis of cohort studies
por: Wang, Xiangyu, et al.
Publicado: (2023)

Nurses’ objective knowledge regarding venous thromboembolism prophylaxis: A national survey study
por: MA, Yu-Fen, et al.
Publicado: (2018)

Direct Oral Anticoagulants and Travel-related Venous Thromboembolism
por: Chamnanchanunt, Supat, et al.
Publicado: (2018)

Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan
por: Nakamura, Mashio, et al.
Publicado: (2017)

Direct oral anticoagulants for unusual‐site venous thromboembolism
por: Riva, Nicoletta, et al.
Publicado: (2021)

Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
por: Masini, Marta, et al.
Publicado: (2023)

Meta-analysis of the efficacy and safety of non-vitamin K antagonist oral anticoagulants with warfarin in Latin American patients with atrial fibrillation
por: Su, Zhiyu, et al.
Publicado: (2020)

The impact of renal function on efficacy and safety of new oral anticoagulant in atrial fibrillation patients: A systemic review and meta-analysis
por: Gui, Yi-yue, et al.
Publicado: (2019)

Efficacy of ultrasound-accelerated versus traditional catheter-directed thrombolysis in treatment of lower extremity deep venous thrombosis: A protocol for systematic review and meta-analysis
por: Ma, Shan, et al.
Publicado: (2021)

The safety and efficacy of oral anticoagulants with dual versus single antiplatelet therapy in patients after percutaneous coronary intervention: A meta-analysis
por: Chen, Jie, et al.
Publicado: (2017)

A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin
por: Tao, Ende, et al.
Publicado: (2020)

Risk profile, management, and outcomes of patients with venous thromboembolism attended in Spanish Emergency Departments: The ESPHERIA registry
por: Jimenez, Sonia, et al.
Publicado: (2017)

Clinical outcomes of comorbid cancer patients with venous thromboembolism: A retrospective, single-center study in Korea
por: Jeong, Jihwan, et al.
Publicado: (2019)

Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism
por: López-Núñez, Juan J., et al.
Publicado: (2019)

Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review
por: Al Mukdad, Mohammad, et al.
Publicado: (2019)

Multiple arterial and venous thromboembolism in a male patient with hereditary protein C deficiency: A case report
por: Sun, Likun, et al.
Publicado: (2021)

A review of venous thromboembolism risk assessment models for different patient populations: What we know and don’t!
por: Mehta, Y, et al.
Publicado: (2023)

Direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism
por: Yhim, Ho-Young, et al.
Publicado: (2014)

Direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer
por: Planquette, Benjamin, et al.
Publicado: (2019)

Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence
por: García-Escobar, I., et al.
Publicado: (2020)

Spinal anesthesia increases the risk of venous thromboembolism in total arthroplasty: Secondary analysis of a J-PSVT cohort study on anesthesia
por: Nakamura, Mashio, et al.
Publicado: (2017)

Can catheter ablation reduce the incidence of thromboembolic events in patients with atrial fibrillation?: Protocol for a systematic review and meta-analysis
por: Liu, Menghui, et al.
Publicado: (2017)

Efficacy and safety of postural intervention on prevention of deep venous thrombosis of lower extremity in postpartum women with pregnancy-induced hypertension: A protocol for systematic review and meta-analysis
por: Chen, Jie, et al.
Publicado: (2021)

Compression Therapy in the Prevention of Postthrombotic Syndrome: A Systematic Review and Meta-Analysis
por: Tie, Hong-Tao, et al.
Publicado: (2015)

New anticoagulants for the prevention of venous thromboembolism
por: Becattini, Cecilia, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_v5k54055ftluic0fjkmhagec87